|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 205/04 | |
| A61K 31/397 | |||
| A61P 29/00 | |||
| A61P 31/06 | |||
| A61P 31/08 | |||
| A61P 21/00 |
| (11) | Patento numeris | 2379498 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09793423.6 |
| Europos patento paraiškos padavimo data | 2009-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-10-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-01-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/068346 |
| Data | 2009-12-17 |
| (87) | Numeris | WO 2010/071794 |
| Data | 2010-06-24 |
| (30) | Numeris | Data | Šalis |
| 203052 P | 2008-12-18 | US |
| (72) |
LIU, Yugang, US
PAPOUTSAKIS, Dimitris, US
RODDY, Elizabeth, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | POLYMORPHIC FORM OF 1-(4-{1-[(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL) -AZETIDINE-3-CARBOXYLIC ACID |
| POLYMORPHIC FORM OF 1-(4-{1-[(E)-4-CYCLOHEXYL-3-TRIFLUOROMETHYL-BENZYLOXYIMINO]-ETHYL}-2-ETHYL-BENZYL) -AZETIDINE-3-CARBOXYLIC ACID |